Skip to main content

Table 3 Acute and elective surgery in individual specialties

From: suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

 

Acute surgery

Elective surgery

 

Type of surgery

n (%)a

Median suPAR

90-days mortality: n (%)

n

Median suPAR

90-days mortality: n (%)

p-value suPARb

p-value mortalityc

Gastroenterological

353 (68.7)

3.7

75 (21.3)

161

3.2

9 (5.6)

0.0032

< 0.0001

Orthopedic

320 (57.7)

4.3

61 (19.1)

235

2.8

5 (2.1)

< 0.0001

< 0.0001

Cardiothoracic

111 (30.3)

2.8

8 (7.2)

255

2.6

3 (1.2)

0.16

0.0041d

Neurological

68 (44.7)

2.9

8 (11.8)

84

2.8

2 (2.4)

0.90

0.043d

Respiratory

357 (86.9)

4.4

131 (36.7)

54

3.1

5 (9.3)

< 0.0001

< 0.0001

Urological

87 (41.6)

4.4

14 (16.1)

122

3.1

5 (4.1)

< 0.0001

0.0029

Minor

381 (87.0)

4.5

114 (29.9)

57

3.8

4 (7.0)

0.065

0.0003

Endoscopies

764 (76.7)

4.2

145 (19.0)

230

3.3

11 (4.8)

< 0.0001

< 0.0001

Gynecological

34 (34.7)

2.8

1 (2.9)

64

2.7

0

0.53

0.17

Obstetrics

231 (89.1)

1.6

0

28

1.8

0

0.50

 

Vascular

54 (36.7)

4.1

12 (22.2)

93

4.2

1 (1.1)

0.96

< 0.0001

Dermatological

161 (80.5)

4.1

29 (18.0)

39

3.7

1 (2.6)

0.022

0.0153d

Other

10 (10.5)

2.5

1 (10.0)

85

2.8

2 (2.4)

0.71

0.19

Cancer-relatede

104 (40.5)

4.1

46 (44.2)

153

3.4

11 (7.2)

0.010

< 0.0001

  1. suPAR soluble urokinase plasminogen activator receptor
  2. aThe percentage of total surgery in the specific specialty
  3. bp-value is calculated for suPAR in acutely vs. electively operated patients
  4. cp-value is calculated for acute 90-day mortality compared with elective 90-day mortality
  5. dFisher’s exact test is used instead of Pearson’s Chi-squared test
  6. eCancer-related surgery is measured as the patient having cancer as the main diagnosis when surgery was performed